103 related articles for article (PubMed ID: 8223403)
1. A study of the advantages and limitations of immunoblotting procedures for the detection of antibodies against influenza virus.
Kapaklis-Deliyannis GP; Drummer HE; Brown LE; Tannock GA; Jackson DC
Electrophoresis; 1993 Sep; 14(9):926-36. PubMed ID: 8223403
[TBL] [Abstract][Full Text] [Related]
2. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
3. Western blot analysis of antibody responses to influenza virion proteins.
Qiu D; Tannock GA; Barry RD; Jackson DC
Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():181-91. PubMed ID: 1452221
[TBL] [Abstract][Full Text] [Related]
4. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
5. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
8. The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.
Gerhard W
J Exp Med; 1976 Oct; 144(4):985-95. PubMed ID: 62020
[TBL] [Abstract][Full Text] [Related]
9. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
Ze C; Kurata T; Tamura S
Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
[TBL] [Abstract][Full Text] [Related]
10. The postvaccination antibody response to influenza virus proteins.
Cox RJ; Brokstad KA
APMIS; 1999 Mar; 107(3):289-96. PubMed ID: 10223301
[TBL] [Abstract][Full Text] [Related]
11. The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection.
Nagy Z; Rajnavölgyi E; Hollósi M; Tóth GK; Váradi G; Penke B; Tóth I; Horváth A; Gergely J; Kurucz I
Scand J Immunol; 1994 Sep; 40(3):281-91. PubMed ID: 8091127
[TBL] [Abstract][Full Text] [Related]
12. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
Johansson BE
Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
[TBL] [Abstract][Full Text] [Related]
13. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin.
Scherle PA; Gerhard W
J Exp Med; 1986 Oct; 164(4):1114-28. PubMed ID: 2944982
[TBL] [Abstract][Full Text] [Related]
15. Conservation of epitopes recognized by monoclonal antibodies against the separated subunits of influenza hemagglutinin among type A viruses of the same and different subtypes.
Sanchez-Fauquier A; Guillen M; Martin J; Kendal AP; Melero JA
Arch Virol; 1991; 116(1-4):285-92. PubMed ID: 1705790
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
[TBL] [Abstract][Full Text] [Related]
17. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
18. An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes.
Lopez JA; Guillen M; Sanchez-Fauquier A; Melero JA
J Virol Methods; 1986 Jun; 13(3):255-64. PubMed ID: 2426296
[TBL] [Abstract][Full Text] [Related]
19. The functions of oligosaccharide chains associated with influenza C viral glycoproteins. II. The role of carbohydrates in the antigenic properties of influenza C viral glycoproteins.
Hongo S; Sugawara K; Homma M; Nakamura K
Arch Virol; 1986; 89(1-4):189-201. PubMed ID: 2424405
[TBL] [Abstract][Full Text] [Related]
20. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.
Staudt LM; Gerhard W
J Exp Med; 1983 Feb; 157(2):687-704. PubMed ID: 6600489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
